AstraZeneca's latest TV ad for Farxiga and kidney disease shows people living with diabetes and hypertension as potential targets.
January 20, 2023 02:56 PM ESTUpdated 03:53 PM
Pharma
Marketing

As­traZeneca ex­pands chron­ic kid­ney dis­ease 'Tar­get' cam­paign for Farx­i­ga

Beth Snyder Bulik

Senior Editor

In its lat­est com­mer­cial for Farx­i­ga, As­traZeneca prompts peo­ple to ask their doc­tor for their kid­ney num­bers. But what does that mean? It’s a pa­tient …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

A service from the Financial Times